Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

• Published in: International journal of cancer Vol. 95; no. 2; pp. 121 - 127
• Main Authors: Hengstler, J.G., Pilch, H., Schmidt, M., Dahlenburg, H., Sagemüller, J., Schiffer, I., Oesch, F., Knapstein, P.G., Kaina, B., Tanner, B.
• Format: Journal Article
• Language: English
• Published: New York John Wiley & Sons, Inc 20.03.2001; Wiley-Liss
• Subjects: Biological and medical sciences; Disease Progression; Disease-Free Survival; Female; Female genital diseases; glutathione; Glutathione - metabolism; Gynecology. Andrology. Obstetrics; histological grade; Humans; Immunohistochemistry; Medical sciences; metallothionein; Metallothionein - biosynthesis; Metallothionein - chemistry; ovarian cancer; Ovarian Neoplasms - diagnosis; Ovarian Neoplasms - metabolism; Ovarian Neoplasms - mortality; Ovarian Neoplasms - surgery; p53; Prognosis; Protein Isoforms; Receptor, ErbB-2 - biosynthesis; Time Factors; Tumor Suppressor Protein p53 - biosynthesis; Tumors; Histological grading; Human; Prognosis; Genetic marker; Malignant tumor; Female genital diseases; Pathology; Ovarian diseases; Ovary; TP53 Gene; Histopathology; Genetics; Mutation; Metallothionein; Glutathione; Tumor suppressor gene
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/1097-0215(20010320)95:2<121::AID-IJC1021>3.0.CO;2-N

Metallothioneins (MTs) and glutathione constitute the major fractions of intracellular thiol factors. Abundant nucleophilic sulfhydryl groups can interact with many electrophilic substances, including several anti‐neoplastic agents, participate in controlling intracellular redox potential, and act as scavengers of reactive oxygen species. In the present study, we examined the relation of MTs (alone and in combination with glutathione) to histopathological parameters and survival time of ovarian cancer patients. Expression of the major MT isoforms (MT‐1 and MT‐2) was determined by immunohistochemistry on paraffin‐embedded tumor specimens from 189 patients, 151 suffering from primary epithelial ovarian cancer and 38 from recurrences. MT was negatively associated with survival time when all patients with primary carcinomas (n = 151) were analyzed (p = 0.049, log‐rank test). However, no significant association between MT expression and survival was obtained when subgroups of patients with histological grade 1, 2 or 3 carcinomas were analyzed. Similarly, no significant association of MT expression and survival was obtained with the proportional hazards model adjusted for histological grade. This scenario can be explained by a correlation between MT expression and histological grade: MT was detectable in 26%, 48% and 62% of grade 1, 2 and 3 carcinomas, respectively (p = 0.008, χ2 test). An interesting hypothesis is generated by combined analysis of MT and total glutathione content (GSH). The product of MT and GSH levels (MT × GSH) was negatively associated with survival of grade 1 carcinomas (p = 0.021, log‐rank test) but not with grade 2 and 3 carcinomas (p = 0.176 and 0.403, respectively). When MT × GSH was greater than the median, 25% of patients with grade 1 carcinomas died within 235 days. In contrast, all patients with grade 1 carcinomas survived when MT × GSH in tumor tissue was smaller than the median. This suggests that high expression of sulfhydryl factors might facilitate survival and progression of low‐grade ovarian cancer cells. A significant correlation was obtained between MT expression and mutant p53 (p = 0.037, χ2 test). However, this might be an indirect effect since both MT (p = 0.008) and mutant p53 (p = 0.000) were associated with histological grade. In conclusion, MT expression as well as the product of MT and GSH were associated with histological grade of primary ovarian carcinomas. High expression of both sulfhydryl factors may identify a subgroup of low‐grade carcinomas with an increased risk of progression. © 2001 Wiley‐Liss, Inc.